IM Cannabis enters LOI to sell European assets to Slil.com, cutting debt by CAD 10.5 million

• IM Cannabis agreed to sell IMC Holdings, which will house its European operations, to Slil.com Holding under a non-binding letter of intent.
• Slil.com would assume about CAD 10.5 million of IM Cannabis debt, including CAD 7.5 million of retained liabilities.
• The deal would transfer the Germany unit Adjupharm, with stakes in Xinteza API and Shiran Societe Anonyme.
• IM Cannabis would keep its Israeli business, shifting focus to Israel while streamlining operations.
• Closing depends on a definitive agreement, board process, any required regulatory clearances, and other customary conditions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IM Cannabis Corp. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202606180732PR_NEWS_USPR_____IO87110) on June 18, 2026, and is solely responsible for the information contained therein.